In a patient with opioid use disorder on buprenorphine who is intubated and receiving a fentanyl infusion, how should withdrawal be managed?

Managing Withdrawal in an Intubated Patient on Buprenorphine Receiving Fentanyl Infusion

Continue the fentanyl infusion for sedation/analgesia while simultaneously converting the patient's home buprenorphine dose to methadone 30-40 mg daily, then use additional short-acting opioids as needed for breakthrough pain or withdrawal symptoms. 1

Core Management Strategy

The fundamental challenge here is that buprenorphine's high μ-receptor affinity blocks full agonist opioids like fentanyl, making both adequate sedation and withdrawal prevention difficult. The solution is to replace buprenorphine with a full agonist that allows predictable dose-response to additional opioids.

Step-by-Step Approach:

1. Convert Buprenorphine to Methadone

• Discontinue buprenorphine immediately upon ICU admission
• Start methadone 30-40 mg daily (given enterally via NG/OG tube if intubated) 1
• This dose prevents acute withdrawal in most patients without requiring precise conversion calculations
• If withdrawal symptoms persist after 24 hours, increase methadone by 5-10 mg increments 1
• Methadone binds less tightly to μ-receptors than buprenorphine, allowing fentanyl and other opioids to work as expected 1

2. Maintain Fentanyl Infusion

• Continue current fentanyl infusion for sedation and mechanical ventilation tolerance
• The methadone addresses baseline opioid dependence; fentanyl addresses acute ICU needs
• Titrate fentanyl to standard ICU sedation goals (RASS score, ventilator synchrony)
• No need to reduce fentanyl initially—the methadone prevents withdrawal from the patient's baseline buprenorphine 1

3. Monitor for Withdrawal Use objective scoring (COWS - Clinical Opiate Withdrawal Scale):

• Tachycardia, hypertension, diaphoresis, mydriasis, piloerection
• Gastrointestinal symptoms (nausea, vomiting, diarrhea)
• Agitation, restlessness (may manifest as ventilator dyssynchrony)

If withdrawal emerges despite methadone:

• Increase methadone dose by 5-10 mg 1
• Consider adjunctive medications: clonidine 0.1-0.2 mg q6h, ondansetron, loperamide 2

4. Extubation Planning When ready to extubate:

• Keep methadone at current dose that prevented withdrawal
• Wean fentanyl infusion gradually over 12-24 hours before extubation
• Convert any remaining fentanyl to scheduled short-acting opioids (morphine or hydromorphone) for post-extubation pain/comfort 3

Alternative Approach: Low-Dose Overlap Initiation (LDOI)

Recent evidence supports continuing buprenorphine alongside fentanyl using a novel protocol, though this is less established:

Low-Dose Buprenorphine Overlap Method 4, 5:

• Start buprenorphine at very low doses (0.5-1 mg sublingual) while continuing full fentanyl infusion
• Gradually escalate buprenorphine over 5-7 days while tapering fentanyl
• This avoids precipitated withdrawal by slowly occupying μ-receptors
• Success rate: 79-92% in ICU patients 4, 5
• Requires pharmacy preparation of split tablets and careful daily titration

LDOI Schedule Example 4:

• Day 1: Buprenorphine 0.5 mg SL + full fentanyl dose
• Day 2: Buprenorphine 1 mg SL + 75% fentanyl
• Day 3: Buprenorphine 2 mg SL + 50% fentanyl
• Days 4-7: Continue escalating buprenorphine to 12-16 mg while weaning fentanyl

However, the methadone conversion approach remains more straightforward and better supported by guidelines 1.

Critical Pitfalls to Avoid

Do NOT simply restart buprenorphine while on fentanyl using traditional dosing—this will precipitate severe withdrawal as buprenorphine displaces fentanyl from receptors 1, 6

Do NOT use mixed agonist-antagonists (nalbuphine, butorphanol, pentazocine)—these can precipitate withdrawal 1

Do NOT underdose methadone—30-40 mg is the minimum effective dose for most patients on buprenorphine maintenance 1

Do NOT forget naloxone at bedside—respiratory depression risk exists when combining methadone with fentanyl infusions 1

Discharge Planning

Before discharge:

• Transition back to buprenorphine using standard induction protocol (requires mild withdrawal, typically 12-24 hours after last methadone dose) 1
• OR continue methadone if patient prefers and arrange outpatient methadone clinic follow-up
• Coordinate with patient's outpatient buprenorphine provider before making changes 1, 6
• Ensure naloxone prescription and harm reduction counseling 2

Why This Approach Works

Buprenorphine's partial agonist properties and extremely high receptor affinity (dissociation half-life >100 minutes) create a "ceiling" that blocks full agonists 1. In the ICU, this prevents adequate sedation and risks withdrawal. Methadone, as a full agonist with lower receptor affinity, allows:

1. Prevention of withdrawal from baseline opioid dependence
2. Predictable response to additional opioids for sedation/analgesia
3. Easier titration without precipitating withdrawal 1

The evidence strongly supports this methadone bridge strategy for hospitalized patients requiring acute pain management or sedation 1.